General

Cartherics welcomes new PhD Student

Monash Grad Rachelle Duffin joins the team

1 March 2021

By Leigh Dayton

Fresh from a Research Assistant job at the Peter MacCallum Cancer Centre and a Bachelor of Science (Honours) from Monash University, Rachelle Duffin took up her new role at Cartherics at the beginning of February.

She’s “delighted and honoured” to be supervised by Cartherics […]

2021-03-01T00:30:55+00:00March 1st, 2021|

Cartherics Makes February 2021 A Special Month

It all happened at Cape Schanck ……

By Leigh Dayton

24 February 2021

2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]

2021-02-24T06:25:41+00:00February 24th, 2021|

CAR-T Funding is Reaching Staggering New Heights

A survey reveals nearly US$100 market capitalisation

23 February 2021

A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.

At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]

2021-02-24T06:18:44+00:00February 23rd, 2021|

Cartherics CEO Alan Trounson on “3-person IVF”

Legislation to be introduced to Australian Parliament

By Leigh Dayton

4 February 2021

Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.

Thanks to this […]

2021-02-04T03:41:18+00:00February 4th, 2021|

Cartherics Celebrates Academic Achievements

Doctoral students achieve key milestones

 By Leigh Dayton

21 December 2020

As a rough year for all comes to an end, Cartherics is delighted to raise a toast to Anisha Balachandran and Van Thi To.  Anisha dressed-up for a pared-down graduation ceremony, and Van passed her Confirmation of Candidature Review with flying colours.

Cartherics CEO Alan Trounson is the […]

2020-12-21T06:35:40+00:00December 21st, 2020|

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+00:00November 19th, 2020|

The Fight Against Cancer Continues ……. Despite COVID-19

18 November 2020

By Leigh Dayton

They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.

Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]

2020-12-09T09:26:07+00:00November 18th, 2020|

Cartherics CEO handed the editorial chair

Alan Trounson guest edits a special immunology issue of the journal Cells

 By Leigh Dayton 9 Nov 2020

 

As well as steering the Melbourne-based biotech company through the challenges of COVID-19, CEO Alan Trounson has taken up the role of guest editor for the prestigious journal Cells.

It’s a perfect match. The journal’s upcoming special issue will […]

2020-12-09T09:28:02+00:00November 9th, 2020|

Nobel Chemistry prize going to CRISPR scientists

Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry

Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors.

The Royal Swedish Academy of Sciences

7 October 2020

Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]

2020-10-09T23:54:50+00:00October 9th, 2020|

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+00:00September 23rd, 2020|